Affordable Access

deepdyve-link
Publisher Website

Inhaled nitric oxide for respiratory failure in preterm infants.

Authors
  • Soll, Roger F
Type
Published Article
Journal
Neonatology
Publication Date
Jan 01, 2012
Volume
102
Issue
4
Pages
251–253
Identifiers
DOI: 10.1159/000338552
PMID: 22907671
Source
Medline
License
Unknown

Abstract

Fourteen randomized controlled trials of iNO therapy in preterm infants were found. The trials have been grouped post hoc into three categories depending on entry criteria: entry in the first 3 days of life based on oxygenation criteria, routine use in preterm babies with pulmonary disease, and later enrolment based on an increased risk of BPD. No overall analyses were performed. Nine trials of early rescue treatment of infants based on oxygenation criteria demonstrated no significant effect of iNO on mortality or BPD. Three studies with routine use of iNO in infants with pulmonary disease also demonstrated no significant reduction in death or BPD [typical RR 0.93 (95% CI 0.86-1.01)] although this small effect approached significance. Later treatment with iNO based on the risk of BPD (two trials) demonstrated no significant benefit for this outcome in analyses which are possible using summary data. There is no clear effect of iNO on the frequency of all grades of IVH or of severe IVH. Early rescue treatment was associated with a non-significant 20% increase in severe IVH. No effect on the incidence of neurodevelopmental impairment was found.

Report this publication

Statistics

Seen <100 times